<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Med Biol Res</journal-id><journal-id journal-id-type="iso-abbrev">Braz. J. Med. Biol. Res</journal-id><journal-title-group><journal-title>Brazilian Journal of Medical and Biological Research</journal-title></journal-title-group><issn pub-type="ppub">0100-879X</issn><issn pub-type="epub">1414-431X</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o Brasileira de Divulga&#x000e7;&#x000e3;o Cient&#x000ed;fica</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24820225</article-id><article-id pub-id-type="pmc">4075310</article-id><article-id pub-id-type="doi">10.1590/1414-431X20143767</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Investigation</subject></subj-group></article-categories><title-group><article-title>Effects of different frequencies of transcutaneous
electrical nerve stimulation on venous vascular reactivity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Franco</surname><given-names>O.S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Paulitsch</surname><given-names>F.S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>A.P.C.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>A.O.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Martins</surname><given-names>C.N.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>A.M.V.</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Plentz</surname><given-names>R.D.M.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Irigoyen</surname><given-names>M.C.</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Signori</surname><given-names>L.U.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><aff id="aff1"><label>1</label> Universidade Federal do Rio Grande, Faculdade de Medicina, Programa
de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias da Sa&#x000fa;de, Rio Grande, RS, Brasil, Programa de
P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias da Sa&#x000fa;de, Faculdade de Medicina, Universidade Federal do
Rio Grande, Rio Grande, RS, Brasil</aff><aff id="aff2"><label>2</label> Universidade Federal do Rio Grande, Instituto de Ci&#x000ea;ncias
Biol&#x000f3;gicas, Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Fisiologia Animal Comparada, Rio Grande, RS,
Brasil, Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Fisiologia Animal Comparada, Instituto de
Ci&#x000ea;ncias Biol&#x000f3;gicas, Universidade Federal do Rio Grande, Rio Grande, RS, Brasil</aff><aff id="aff3"><label>3</label> Universidade Federal de Santa Maria, Departamento de Fisioterapia e
Reabilita&#x000e7;&#x000e3;o, Santa Maria, RS, Brasil, Departamento de Fisioterapia e Reabilita&#x000e7;&#x000e3;o,
Universidade Federal de Santa Maria, Santa Maria, RS, Brasil</aff><aff id="aff4"><label>4</label> Universidade Federal de Ci&#x000ea;ncias da Sa&#x000fa;de de Porto Alegre, Programa
de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias da Reabilita&#x000e7;&#x000e3;o, Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias
da Sa&#x000fa;de, Porto Alegre, RS, Brasil, Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias da Sa&#x000fa;de,
Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Ci&#x000ea;ncias da Reabilita&#x000e7;&#x000e3;o, Universidade Federal de
Ci&#x000ea;ncias da Sa&#x000fa;de de Porto Alegre, Porto Alegre, RS, Brasil</aff><aff id="aff5"><label>5</label> Faculdade de Medicina, Universidade de S&#x000e3;o Paulo, Instituto do
Cora&#x000e7;&#x000e3;o, Unidade de Hipertens&#x000e3;o, S&#x000e3;o Paulo, SP, Brasil, Unidade de Hipertens&#x000e3;o,
Instituto do Cora&#x000e7;&#x000e3;o, Faculdade de Medicina, Universidade de S&#x000e3;o Paulo, S&#x000e3;o Paulo,
SP, Brasil</aff></contrib-group><author-notes><corresp>Correspondence: L.U. Signori, Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas, Universidade
Federal do Rio Grande, Av. It&#x000e1;lia km 8, 96201-900 Rio Grande, RS, Brasil,
+55-53-3233-6633. E-mail: <email>l.signori@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>04</day><month>4</month><year>2014</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2014</year></pub-date><volume>47</volume><issue>5</issue><fpage>411</fpage><lpage>418</lpage><history><date date-type="received"><day>12</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>10</day><month>2</month><year>2014</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p></license></permissions><abstract><p>Transcutaneous electrical nerve stimulation (TENS) is a type of therapy used
primarily for analgesia, but also presents changes in the cardiovascular system
responses; its effects are dependent upon application parameters. Alterations to the
cardiovascular system suggest that TENS may modify venous vascular response. The
objective of this study was to evaluate the effects of TENS at different frequencies
(10 and 100 Hz) on venous vascular reactivity in healthy subjects. Twenty-nine
healthy male volunteers were randomized into three groups: placebo (n=10),
low-frequency TENS (10 Hz, n=9) and high-frequency TENS (100 Hz, n=10). TENS was
applied for 30 min in the nervous plexus trajectory from the superior member (from
cervical to dorsal region of the fist) at low (10 Hz/200 &#x003bc;s) and high frequency (100
Hz/200 &#x003bc;s) with its intensity adjusted below the motor threshold and intensified
every 5 min, intending to avoid accommodation. Venous vascular reactivity in response
to phenylephrine, acetylcholine (endothelium-dependent) and sodium nitroprusside
(endothelium-independent) was assessed by the dorsal hand vein technique. The
phenylephrine effective dose to achieve 70% vasoconstriction was reduced 53%
(P&#x0003c;0.01) using low-frequency TENS (10 Hz), while in high-frequency stimulation
(100 Hz), a 47% increased dose was needed (P&#x0003c;0.01). The endothelium-dependent
(acetylcholine) and independent (sodium nitroprusside) responses were not modified by
TENS, which modifies venous responsiveness, and increases the low-frequency
sensitivity of &#x003b1;1-adrenergic receptors and shows high-frequency opposite effects.
These changes represent an important vascular effect caused by TENS with implications
for hemodynamics, inflammation and analgesia.</p></abstract><kwd-group><kwd>Electric stimulation therapy</kwd><kwd>Vascular endothelium</kwd><kwd>Alpha-1 adrenergic receptors</kwd><kwd>Mechanical pain</kwd></kwd-group><counts><fig-count count="3"/><table-count count="2"/><ref-count count="34"/><page-count count="8"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Transcutaneous electric nervous stimulation (TENS) has been widely used as a tool for
treatment of acute and chronic pain. However, this therapeutic modality modifies the
cardiovascular system responses, causing vasodilation (<xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B02" ref-type="bibr">2</xref>), increasing blood flow (<xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B03" ref-type="bibr">3</xref>-<xref rid="B05" ref-type="bibr">5</xref>), and decreasing peripheral vascular resistance
(<xref rid="B06" ref-type="bibr">6</xref>-<xref rid="B08" ref-type="bibr">8</xref>),
heart rate (<xref rid="B09" ref-type="bibr">9</xref>) and systemic arterial blood
pressure (<xref rid="B02" ref-type="bibr">2</xref>,<xref rid="B08" ref-type="bibr">8</xref>,<xref rid="B09" ref-type="bibr">9</xref>), all of which are associated with
modulating the autonomic balance (<xref rid="B02" ref-type="bibr">2</xref>,<xref rid="B10" ref-type="bibr">10</xref>). Therefore, some studies have focused on the
application of the mentioned therapeutic tools in the treatment of other clinical
conditions, such as those involving the alteration of systemic arterial pressure, as
observed for hypertension (<xref rid="B02" ref-type="bibr">2</xref>,<xref rid="B11" ref-type="bibr">11</xref>-<xref rid="B13" ref-type="bibr">13</xref>) and
diabetes (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B15" ref-type="bibr">15</xref>).</p><p>TENS parameters are variable, according to intensity, frequency, pulse duration,
positioning of the electrodes and application time (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>). Regarding the cardiovascular
system, the pulse frequency appears to present different hemodynamic responses, usually
applied at low (&#x0003c;10 Hz) or high (&#x0003e;50 Hz) frequencies (<xref rid="B17" ref-type="bibr">17</xref>). The application of acute TENS at low frequencies (2 and 4 Hz)
produced a local increase of muscular (<xref rid="B05" ref-type="bibr">5</xref>) and
cutaneous (<xref rid="B04" ref-type="bibr">4</xref>) blood flow. On the other hand, at
high frequencies (80 and 110 Hz), these alterations were not noticed. However, high
frequency (80 Hz) promoted vasodilatation, reduced systemic arterial blood pressure, and
improved sympathetic-vagal balance during exercise (<xref rid="B02" ref-type="bibr">2</xref>). Also, when applied in the precordial region (70 and 150 Hz), it reduced
serum levels of catecholamines in patients with angina pectoris (<xref rid="B03" ref-type="bibr">3</xref>,<xref rid="B07" ref-type="bibr">7</xref>).</p><p>Alterations caused by TENS on the cardiovascular system (<xref rid="B01" ref-type="bibr">1</xref>-<xref rid="B10" ref-type="bibr">10</xref>), especially the changes to the
autonomic nervous system (<xref rid="B02" ref-type="bibr">2</xref>,<xref rid="B10" ref-type="bibr">10</xref>), possibly interact with the layer of endothelial cells, because
these share a functional antagonism with sympathetic nervous system efferents in
maintaining blood vessel tone (<xref rid="B18" ref-type="bibr">18</xref>). The
endothelium constitutes a dynamic tissue, which is interposed between the blood and the
smooth muscle layer of blood vessels, and is responsive to physical and chemical
stimuli, with consequent synthesis and/or release of regulatory substances that affect
the vascular tonus, its growth, and platelet and leukocyte aggregation. In addition, it
modulates the interaction among these cells (<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref>).</p><p>The effects of TENS on venous vascular reactivity and endothelium venous function have
not yet been investigated, and the changes in the cardiovascular system are dependent on
the application parameters (<xref rid="B04" ref-type="bibr">4</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>). Based
on the information described above, we hypothesized that different application
parameters of this electrical stimulation modify these variables of the cardiovascular
system. The aim of this study was to evaluate the effects of different frequencies (10
and 100 Hz) of TENS on venous vascular reactivity in healthy volunteers.</p></sec><sec sec-type="materials|methods"><title>Material and Methods</title><sec><title>Setting and participants</title><p>The study was approved by the Health Research Ethics Committee at Universidade
Federal do Rio Grande, Brazil (CEPAS-FURG, No. 78/2011), and all subjects provided
written informed consent. The evaluations were carried out from December 2011 to
December 2012 at Dr. Miguel Riet Corr&#x000ea;a Jr. University Hospital, Universidade Federal
do Rio Grande (Rio Grande, RS, Brazil). The subjects who joined the study were
between 20 and 35 years of age; presenting a body mass index (kg/m<sup>2</sup>) lower
than 30; nonsmokers; with no symptoms of skeletal muscle disorders; with no previous
diagnosis of rheumatic, cardiovascular, metabolic, neurological, oncological, immune,
or hematological diseases; with no evidence of psychiatric and/or cognitive
disorders; and were not using any type of medication. Volunteers presenting
inflammatory response (C-reactive protein &#x0003e;3 mg/dL, fibrinogen &#x0003c;200 or &#x0003e;400
mg/dL) or leukocytosis (11.000&#x000d7;10<sup>3</sup>/mm<sup>3</sup>) or who had consumed
alcoholic beverages up to 24 h before the test were excluded.</p></sec><sec><title>Study design</title><p>The sample was composed of 30 volunteers (according to the sample calculation),
randomized by a computer program (<ext-link ext-link-type="uri" xlink:href="http://www.random.org">www.random.org</ext-link>).
The information was sealed in a brown envelope, and the groups and evaluators were
blinded to the type of intervention. The groups were divided into the placebo group
(n=10), the low-frequency TENS group (10 Hz, n=9), and the high-frequency TENS group
(100 Hz, n=10). After data collection, one volunteer was excluded due to evidence of
leukocytosis and high C-reactive protein levels. A flowchart of the volunteers is
presented in <xref ref-type="fig" rid="f01">Figure 1</xref>. Venous endothelial
function was evaluated before and immediately after the application of TENS. To
prevent postprandial metabolic interference, volunteers underwent a 12-h fasting
period (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>) and remained in this condition during the experimental protocol.</p><fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Flowchart of the volunteers in the study.</title></caption><graphic xlink:href="1414-431X-bjmbr-47-05-00411-gf001"/></fig></sec><sec><title>Interventions</title><p>During the application of the protocol, the volunteers were lying comfortably in a
supine position, with a head elevation of 30&#x000b0;, resting their knees and elbows over
the bed. The spots where the electrodes were placed were previously cleaned with 70%
alcohol. TENS equipment (Quark, model Nemesys 941, Brazil), waveform biphasic
symmetric, was applied on the nervous plexus trajectory from the superior member.
Autoadhesive electrodes (5&#x000d7;5 cm area) were used and placed distally in the dorsal
region of the wrist and in the proximal region of the cervicothoracic region (between
C4 and T1), as shown in <xref ref-type="fig" rid="f02">Figure 2</xref>. TENS was
applied for 30 min at a low (TENS, 10 Hz/200 &#x003bc;s) or high (TENS, 100 Hz/200 &#x003bc;s)
frequency. The intensity of the current was adjusted, initially and after every 5
min, under the motor threshold. The aforementioned procedures were repeated in the
placebo group with the equipment turned off. The equipment was standardized before
and after data collection.</p><fig id="f02" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Location of electrodes.</title></caption><graphic xlink:href="1414-431X-bjmbr-47-05-00411-gf002"/></fig></sec><sec><title>Measurements</title><p>Venous endothelial function was assessed in all volunteers with the dorsal hand vein
technique. This method was previously described by Aellig (<xref rid="B21" ref-type="bibr">21</xref>). Briefly, a 23-gauge butterfly needle was inserted into a
suitable vein on the back of the hand, and a continuous infusion of physiological
saline (0.3 mL/min) was started. A tripod holding a linear variable differential
transformer (LVDT; Shaevitz Engineering, USA) was mounted on the hand with the
central aperture of the LVDT that contained a movable metallic core at a distance of
10 mm downstream from the tip of the needle. The signal output of the LVDT, which is
linearly proportional to the vertical movement of the core, provided a measurement of
the vein diameter. Readings were taken at a congestive pressure of 40 mmHg by
inflating a blood pressure cuff placed on the upper portion of the arm being studied.
The diameter of the vein during saline infusion with the cuff inflated was defined as
100% relaxation. Afterward, the vein was preconstricted, by infusing increasing doses
(7 min each) of the &#x003b1;1-adrenergic selective agonist phenylephrine (37-25,000 ng/mL),
until the dose that produced approximately 70% constriction of the vein
(ED<sub>70</sub>) was found. This degree of preconstriction was defined as 0%
venodilation. Endothelium-dependent venodilation was assessed with incremental
infusions (6 doses for 3 min each dose) of acetylcholine (12-12,000 ng/mL).
Endothelium-independent (3 doses) vasodilation was assessed with sodium nitroprusside
(156-3,125 ng/mL). Both were calculated as the percentage range between 100 and 0%
venodilation. The individual effects were analyzed as the percentage of maximum
venodilation (<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>-<xref rid="B25" ref-type="bibr">25</xref>). Drugs were infused
with a Harvard infusion pump (Harvard Apparatus Inc., USA). Blood pressure and heart
rate were monitored in the contralateral arm with a sphygmomanometer. Ambient
temperature was kept constant (23&#x000b0;-25&#x000b0;C).</p><p>Cholesterol, triglycerides, high-density lipoproteins, glucose, and urea were
measured using Labtest kits (Labtest Diagn&#x000f3;stica SA, Brazil) and analyzed using Lab
Max 240<sup>&#x000af;</sup> (Japan) equipment. Low-density lipoproteins were calculated by
Friedewald's formula. Fibrinogen was analyzed by Start (Diagnostica Stago, France)
equipment using a Labtest kit. Ultrasensitive C-reactive protein was evaluated by
nephelometry (nephelometer model IMMAGE using laboratory reagent CCRP, Beckman
Coulter, USA). Hemogram blood tests (erythrogram and leukogram) were automatically
processed using ABX kits (Horiba Diagn&#x000f3;stica, Brazil) and also by microscopy. Glucose
levels were measured by the Trinder assay (calorimetry) in Lab Max 240<sup>&#x000af;</sup>
equipment. Insulin was assessed by chemiluminescence using Immulite<sup>&#x000af;</sup> DPC
equipment (Diagnostic Products Corporation, USA). Glycosylated hemoglobin was
determined by an enzymatic method using Lab Max 240<sup>&#x000af;</sup> equipment.</p></sec><sec><title>Sample calculation</title><p>We estimated that a sample size of 9 individuals in each group would have a power of
80% to detect a 60% difference between means (phenylephrine dose) of 70% constriction
of the vein (ED<sub>70</sub>) with 40% standard deviation, for &#x003b1;=0.05.</p></sec><sec><title>Data analysis</title><p>All continuous variables were tested for normal distribution with the
Kolmogorov-Smirnov test. Continuous variables are reported as means&#x000b1;SD if normally
distributed; otherwise, they are reported as median with 25th and 75th percentiles.
Variations between drug dose (dose after minus dose before) are reported as mean
differences and 95% confidence intervals (95%CI). Variables that did not have a
Gaussian distribution were log transformed before further analysis
(log<sub>10</sub>). Differences between the characteristics of the groups were tested
with one-way analysis of variance (ANOVA). For data obtained on two occasions, a
two-way repeated-measure ANOVA followed by the Bonferroni <italic>post hoc</italic>
test was applied. P&#x0003c;0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type="results"><title>Results</title><p>The characteristics of the volunteers are shown in <xref ref-type="table" rid="t01">Table 1</xref>. The groups did not present differences regarding physical or
biochemical variables. The 29 volunteers were normotensive, eutrophic, and
normoglycemic, with no evidence of inflammatory processes and presenting all of the
remaining blood biochemical variables under normal conditions.</p><p>
<table-wrap id="t01" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-47-05-00411-gt001"/></table-wrap>
</p><p>Venous endothelial function data are reported in <xref ref-type="table" rid="t02">Table
2</xref>. Venoconstriction percentages (ED<sub>70</sub>) in response to phenylephrine
and maximum venodilation (Emax) responses (endothelium-dependent, in response to
acetylcholine, and endothelium-independent, in response to sodium nitroprusside) were
not modified in response to TENS. Phenylephrine, acetylcholine, and nitroprusside doses
were similar among groups before TENS application. The necessary phenylephrine dose to
reach ED<sub>70</sub> after TENS application remained the same in the placebo group.
However, the application of TENS at low frequencies (10 Hz) decreased the phenylephrine
dose to reach ED<sub>70</sub> by 53% (P&#x0003c;0.01, mean difference &#x02212;39.6 ng/mL, 95%CI=&#x02212;57
to &#x02212;21). On the other hand, after high-frequency stimulus (100 Hz), a 47% higher
phenylephrine dose was necessary (P&#x0003c;0.01, mean difference 90.0 ng/mL, 95%CI=19-160)
to reach this effect (group: P=0.011, interaction: P&#x0003c;0.001; data are reported as
log<sub>10</sub> in <xref ref-type="fig" rid="f03">Figure 3</xref>). TENS did not
change the doses of acetylcholine and sodium nitroprusside required to reach Emax.
Arterial systolic and diastolic pressures were not modified after the application of
different frequencies of TENS (data not shown).</p><fig id="f03" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Phenylephrine dose required to reach ED<sub>70%</sub> of venoconstriction.
Data are reported as means&#x000b1;SD. *P&#x0003c;0.05, before <italic>vs</italic> after;
<sup>#</sup>P&#x0003c;0.05, TENS <italic>vs</italic> placebo; <sup>+</sup>P&#x0003c;0.05,
TENS 10 Hz <italic>vs</italic> TENS 100 Hz (two-way ANOVA with repeated measures
followed by the Bonferroni test).</title></caption><graphic xlink:href="1414-431X-bjmbr-47-05-00411-gf003"/></fig><p>
<table-wrap id="t02" orientation="portrait" position="float"><graphic xlink:href="1414-431X-bjmbr-47-05-00411-gt002"/></table-wrap>
</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Our data showed that TENS modified the venous response and different stimulation
frequencies increase or diminish the sensitivity of &#x003b1;1-adrenergic receptors. Low
frequencies (10 Hz) increased and high frequencies (100 Hz) decreased the sensitivity of
these receptors, demonstrating that different stimulus frequencies promote opposite
effects on these receptors, depending on TENS application. Regarding the cardiovascular
system, the &#x003b1;1-adrenergic receptor alters vasomotricity, modulating peripheral vascular
resistance by venoconstriction, and cooperating with systemic arterial blood pressure
adjustments by venous return, in response to sympathetic nervous system stimulation by
catecholamines (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>). Noradrenalin (relatively nonselective) and adrenalin (lightly
selective for &#x003b1;2-adrenoceptors) are the catecholamines acting on &#x003b1;1- and &#x003b1;2-adrenoceptor
peripherals interfering in blood circulation (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B27" ref-type="bibr">27</xref>), and the main sources are
circulation and local release from postganglion sympathetic nerve fibers (<xref rid="B28" ref-type="bibr">28</xref>). The increase in the endogenous catecholamines
is associated with modulation of pain and the innate immune response (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B29" ref-type="bibr">29</xref>).</p><p>&#x003b1;1-adrenergic receptor sensitivity changes in response to different frequencies of TENS
application, which might be caused by variations in plasma concentrations of
catecholamines or by direct effects on receptors. For patients presenting angina
pectoris, TENS, when applied on the precordial region at high frequencies (150 and 70
Hz), diminishes peripheral vascular resistance and arterial systolic pressure (<xref rid="B07" ref-type="bibr">7</xref>) by reducing serum levels of adrenalin (<xref rid="B03" ref-type="bibr">3</xref>,<xref rid="B07" ref-type="bibr">7</xref>) and
noradrenalin (<xref rid="B07" ref-type="bibr">7</xref>) and increasing coronary blood
flow, suggesting that these alterations occur at the microcirculation level (<xref rid="B03" ref-type="bibr">3</xref>). Despite the levels of these neurotransmitters
not being measured in the present study, the mentioned studies present a hypothesis for
the effect found in our research, as catecholamines are the agonists of &#x003b1;1- and
&#x003b1;2-adrenergic receptors (<xref rid="B26" ref-type="bibr">26</xref>,<xref rid="B30" ref-type="bibr">30</xref>) and were decreased after TENS application.</p><p>Another mechanism proposed for sensitivity alterations of &#x003b1;1-adrenergic receptors is the
local activation of sympathetic postganglion fibers. Sherry et al. (<xref rid="B08" ref-type="bibr">8</xref>) have demonstrated that TENS at low frequencies
promotes the circulatory alterations caused by the stimulation of sympathetic
postganglion efferent fibers. TENS at low frequencies produced small and transitory
increases in the blood flow and reduced the cutaneous temperature, suggesting that these
responses were not evinced at high frequencies (<xref rid="B04" ref-type="bibr">4</xref>,<xref rid="B31" ref-type="bibr">31</xref>). This increase in blood flow was
also demonstrated in the skeletal musculature, but only for TENS at low frequencies
(<xref rid="B05" ref-type="bibr">5</xref>). Miller et al. (<xref rid="B01" ref-type="bibr">1</xref>) have shown that the increase in blood flow and reduction of
peripheral vascular resistance are similar to voluntary muscle contractions, as TENS at
low frequencies has increased the persistence of this effect. This method of TENS
application favors skeletal muscle contraction (<xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B05" ref-type="bibr">5</xref>), which leads to an increase in
blood flow due to arterial vasodilation and local venoconstriction (<xref rid="B26" ref-type="bibr">26</xref>). Therefore, this state of venous preconstriction
would promote a greater sensitivity of the &#x003b1;1-adrenergic receptors found in our study
after the application of low-frequency TENS.</p><p>The results of clinical effectiveness from different TENS frequencies on the hemodynamic
response are controversial. For healthy subjects, low-frequency TENS reduced sympathetic
and increased parasympathetic modulation; however, at high frequencies, these results
were the opposite (<xref rid="B10" ref-type="bibr">10</xref>). In this regard, the
chronic application of low-frequency TENS reduced arterial systolic and diastolic
pressure in hypertensive patients (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>). However, recent studies have demonstrated that,
at low frequency, TENS did not modify the values of systemic arterial pressure in
normotensive (<xref rid="B32" ref-type="bibr">32</xref>) and hypertensive volunteers
(<xref rid="B13" ref-type="bibr">13</xref>). On the other hand, high-frequency TENS
decreased heart rate, systolic arterial pressure, and the double product in healthy
volunteers (<xref rid="B09" ref-type="bibr">9</xref>). For hypertensive patients, this
method of application promoted a decrease in systemic arterial pressure and metaboreflex
and vasoconstriction responses, leading to an improvement of the sympathetic-vagal
balance during exercise (<xref rid="B02" ref-type="bibr">2</xref>). Our results suggest
that the hemodynamic alterations produced by different frequencies of TENS present a
biphasic sympathetic response of &#x003b1;1-adrenergic receptors. Moreover, it should be
emphasized that the different hemodynamic responses are related to other parameters
(intensity, frequency, pulse duration, electrode positioning, and application time) of
TENS application (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>), as well as to different types of populations studied.
Therefore, the results of this study, regarding frequency, differ from each other and
must be analyzed according to the context in which they were carried out.</p><p>Borderline hypertensive patients and young descendants of hypertensive persons have
presented lower venous compliance, partly due to the increase in venoconstriction
mediated by &#x003b1;1-adrenergic receptors (<xref rid="B33" ref-type="bibr">33</xref>). TENS
peripherally applied at high frequencies reduces the sensitivity of these receptors and
increases venous compliance, which favors the reduction of systemic arterial pressure,
for this clinical condition, and allows, therefore, the perception of a potential
nonpharmacological therapy, especially for patients presenting refractory hypertension
and/or hypertensive crisis. In the present study, it should be highlighted that no
modifications in systemic arterial pressure were observed and, although the study was
not designed to analyze this closure, the authors believe that this fact is due to the
normotensive characteristic of the volunteers and also due to the small area of TENS
application (superior member).</p><p>To understand the analgesic and anti-inflammatory implications caused by the changes in
&#x003b1;1-adrenergic receptor sensitivity in response to TENS application, it should be
emphasized that the sympathetic nervous system is an important regulatory mechanism for
the innate immune response (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B29" ref-type="bibr">29</xref>). King et al. (<xref rid="B30" ref-type="bibr">30</xref>) have demonstrated in an experimental study that TENS at low and high
frequencies modifies the sensitivity of peripheral &#x003b1;2-adrenergic receptors and that this
mechanism contributes to the analgesia efficiency mediated by this method. On the other
hand, &#x003b1;1-adrenergic receptors seem to present postinflammatory effects as a response to
the immune system, especially chronic inflammatory effects (<xref rid="B34" ref-type="bibr">34</xref>). Studies involving human cell cultures have shown that the
expression of these receptors in monocytes and macrophages increases interleukin (IL)-1
production (<xref rid="B31" ref-type="bibr">31</xref>). The same occurs in fibroblasts
and cardiomyocytes, in which stimulation of the mentioned receptors promotes the
expression and production of IL-6 (<xref rid="B34" ref-type="bibr">34</xref>). Regarding
both situations, p38 mitogen-activated protein kinase and nuclear factor-&#x003ba;B pathways are
involved (<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B34" ref-type="bibr">34</xref>). These cells directly interact with the vascular endothelium (<xref rid="B19" ref-type="bibr">19</xref>), and this might be one mechanism by which
alteration in the function of &#x003b1;1-adrenergic receptors induced by TENS can interfere in
the inflammatory response. The absence of plasma catecholamine measures and the local
application of TENS are the limitations of the present study.</p><p>In conclusion, TENS modifies venous responsiveness verified by changed responses of
venoconstriction and &#x003b1;1-adrenergic receptors, considering that low frequency increases
and high frequency reduces the sensitivity of these receptors. These data present a new
action mechanism of TENS on the cardiovascular system that may have implications on the
hemodynamic and inflammatory responses in healthy or diseased subjects.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Laborat&#x000f3;rio de An&#x000e1;lises Cl&#x000ed;nicas, Associa&#x000e7;&#x000e3;o de Caridade Santa
Casa de Rio Grande, and Instituto de Ci&#x000ea;ncias Biol&#x000f3;gicas, Universidade Federal do Rio
Grande, for their collaboration with data processing and analysis.</p></ack><fn-group><fn fn-type="other"><p>First published online May 2, 2014.</p></fn></fn-group><ref-list><title>References</title><ref id="B01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>BF</given-names></name><name><surname>Gruben</surname><given-names>KG</given-names></name><name><surname>Morgan</surname><given-names>BJ</given-names></name></person-group><article-title>Circulatory responses to voluntary and electrically
induced muscle contractions in humans</article-title><source>Phys Ther</source><year>2000</year><volume>80</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">10623959</pub-id></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>PJ</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name><name><surname>Cipriano</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Umpierre</surname><given-names>D</given-names></name><name><surname>Cahalin</surname><given-names>LP</given-names></name><name><surname>Moraes</surname><given-names>RS</given-names></name><etal/></person-group><article-title>Effect of transcutaneous electrical nerve stimulation on
muscle metaboreflex in healthy young and older subjects</article-title><source>Eur J Appl Physiol</source><year>2012</year><volume>112</volume><fpage>1327</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.1007/s00421-011-2084-z</pub-id><pub-id pub-id-type="pmid">21796410</pub-id></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>A</given-names></name><name><surname>Mullins</surname><given-names>PA</given-names></name><name><surname>Thuraisingham</surname><given-names>SI</given-names></name><name><surname>Taylor</surname><given-names>G</given-names></name><name><surname>Petch</surname><given-names>MC</given-names></name><name><surname>Schofield</surname><given-names>PM</given-names></name></person-group><article-title>Effect of transcutaneous electrical nerve stimulation on
coronary blood flow</article-title><source>Circulation</source><year>1994</year><volume>89</volume><fpage>694</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.89.2.694</pub-id><pub-id pub-id-type="pmid">8313557</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cramp</surname><given-names>AF</given-names></name><name><surname>Gilsenan</surname><given-names>C</given-names></name><name><surname>Lowe</surname><given-names>AS</given-names></name><name><surname>Walsh</surname><given-names>DM</given-names></name></person-group><article-title>The effect of high- and low-frequency transcutaneous
electrical nerve stimulation upon cutaneous blood flow and skin temperature in
healthy subjects</article-title><source>Clin Physiol</source><year>2000</year><volume>20</volume><fpage>150</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2281.2000.00240.x</pub-id><pub-id pub-id-type="pmid">10735983</pub-id></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandberg</surname><given-names>ML</given-names></name><name><surname>Sandberg</surname><given-names>MK</given-names></name><name><surname>Dahl</surname><given-names>J</given-names></name></person-group><article-title>Blood flow changes in the trapezius muscle and overlying
skin following transcutaneous electrical nerve stimulation</article-title><source>Phys Ther</source><year>2007</year><volume>87</volume><fpage>1047</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.2522/ptj.20060178</pub-id><pub-id pub-id-type="pmid">17578938</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannheimer</surname><given-names>C</given-names></name><name><surname>Carlsson</surname><given-names>CA</given-names></name><name><surname>Vedin</surname><given-names>A</given-names></name><name><surname>Wilhelmsson</surname><given-names>C</given-names></name></person-group><article-title>Transcutaneous electrical nerve stimulation (TENS) in
angina pectoris</article-title><source>Pain</source><year>1986</year><volume>26</volume><fpage>291</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(86)90058-8</pub-id><pub-id pub-id-type="pmid">3534690</pub-id></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannheimer</surname><given-names>C</given-names></name><name><surname>Emanuelsson</surname><given-names>H</given-names></name><name><surname>Waagstein</surname><given-names>F</given-names></name></person-group><article-title>The effect of transcutaneous electrical nerve
stimulation (TENS) on catecholamine metabolism during pacing-induced angina
pectoris and the influence of naloxone</article-title><source>Pain</source><year>1990</year><volume>41</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(90)91105-R</pub-id><pub-id pub-id-type="pmid">2352762</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sherry</surname><given-names>JE</given-names></name><name><surname>Oehrlein</surname><given-names>KM</given-names></name><name><surname>Hegge</surname><given-names>KS</given-names></name><name><surname>Morgan</surname><given-names>BJ</given-names></name></person-group><article-title>Effect of burst-mode transcutaneous electrical nerve
stimulation on peripheral vascular resistance</article-title><source>Phys Ther</source><year>2001</year><volume>81</volume><fpage>1183</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">11380274</pub-id></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitz</surname><given-names>J</given-names></name></person-group><article-title>Haemodynamic response to TENS applied to the upper
thoracic nerve roots in normal subjects</article-title><source>Hong Kong Physiother J</source><year>2003</year><volume>21</volume><fpage>58</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/S1013-7025(09)70041-7</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>C</given-names></name><name><surname>Dal Lago</surname><given-names>P</given-names></name><name><surname>Ferreira</surname><given-names>JB</given-names></name><name><surname>Casali</surname><given-names>KR</given-names></name><name><surname>Plentz</surname><given-names>RD</given-names></name></person-group><article-title>Transcutaneous electrical nerve stimulation at different
frequencies on heart rate variability in healthy subjects</article-title><source>Auton Neurosci</source><year>2011</year><volume>165</volume><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.autneu.2011.07.003</pub-id><pub-id pub-id-type="pmid">21827970</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaada</surname><given-names>B</given-names></name><name><surname>Flatheim</surname><given-names>E</given-names></name><name><surname>Woie</surname><given-names>L</given-names></name></person-group><article-title>Low-frequency transcutaneous nerve stimulation in
mild/moderate hypertension</article-title><source>Clin Physiol</source><year>1991</year><volume>11</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1111/j.1475-097X.1991.tb00109.x</pub-id><pub-id pub-id-type="pmid">1645634</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobsson</surname><given-names>F</given-names></name><name><surname>Himmelmann</surname><given-names>A</given-names></name><name><surname>Bergbrant</surname><given-names>A</given-names></name><name><surname>Svensson</surname><given-names>A</given-names></name><name><surname>Mannheimer</surname><given-names>C</given-names></name></person-group><article-title>The effect of transcutaneous electric nerve stimulation
in patients with therapy-resistant hypertension</article-title><source>J Hum Hypertens</source><year>2000</year><volume>14</volume><fpage>795</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1038/sj.jhh.1001112</pub-id><pub-id pub-id-type="pmid">11114695</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silverdal</surname><given-names>J</given-names></name><name><surname>Mourtzinis</surname><given-names>G</given-names></name><name><surname>Stener-Victorin</surname><given-names>E</given-names></name><name><surname>Mannheimer</surname><given-names>C</given-names></name><name><surname>Manhem</surname><given-names>K</given-names></name></person-group><article-title>Antihypertensive effect of low-frequency transcutaneous
electrical nerve stimulation (TENS) in comparison with drug
treatment</article-title><source>Blood Press</source><year>2012</year><volume>21</volume><fpage>306</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.3109/08037051.2012.680737</pub-id><pub-id pub-id-type="pmid">22563948</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>JD</given-names></name><name><surname>Wang</surname><given-names>HC</given-names></name><name><surname>Zhao</surname><given-names>JY</given-names></name><name><surname>Zhao</surname><given-names>CL</given-names></name><name><surname>Zhai</surname><given-names>X</given-names></name></person-group><article-title>[Effects of different frequencies of electroacupuncture
on blood glucose level in impaired glucose tolerance patients]</article-title><source>Zhen Ci Yan Jiu</source><year>2011</year><volume>36</volume><fpage>220</fpage><lpage>223</lpage><pub-id pub-id-type="pmid">21793389</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MU</given-names></name></person-group><article-title>Is there a role for TENS application in the control of
diabetes mellitus in insulin-dependent patients?</article-title><source>Singapore Med J</source><year>2012</year><volume>53</volume><fpage>e249</fpage><lpage>e250</lpage><pub-id pub-id-type="pmid">23192517</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalkrishnan</surname><given-names>P</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name></person-group><article-title>Effect of varying frequency, intensity, and pulse
duration of transcutaneous electrical nerve stimulation on primary hyperalgesia in
inflamed rats</article-title><source>Arch Phys Med Rehabil</source><year>2000</year><volume>81</volume><fpage>984</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1053/apmr.2000.5576</pub-id><pub-id pub-id-type="pmid">10896017</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chesterton</surname><given-names>LS</given-names></name><name><surname>Foster</surname><given-names>NE</given-names></name><name><surname>Wright</surname><given-names>CC</given-names></name><name><surname>Baxter</surname><given-names>GD</given-names></name><name><surname>Barlas</surname><given-names>P</given-names></name></person-group><article-title>Effects of TENS frequency, intensity and stimulation
site parameter manipulation on pressure pain thresholds in healthy human
subjects</article-title><source>Pain</source><year>2003</year><volume>106</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/S0304-3959(03)00292-6</pub-id><pub-id pub-id-type="pmid">14581113</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>KF</given-names></name><name><surname>Matthews</surname><given-names>KA</given-names></name></person-group><article-title>Interactions between autonomic nervous system activity
and endothelial function: a model for the development of cardiovascular
disease</article-title><source>Psychosom Med</source><year>2004</year><volume>66</volume><fpage>153</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1097/01.psy.0000116719.95524.e2</pub-id><pub-id pub-id-type="pmid">15039499</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trepels</surname><given-names>T</given-names></name><name><surname>Zeiher</surname><given-names>AM</given-names></name><name><surname>Fichtlscherer</surname><given-names>S</given-names></name></person-group><article-title>The endothelium and inflammation</article-title><source>Endothelium</source><year>2006</year><volume>13</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1080/10623320601061862</pub-id><pub-id pub-id-type="pmid">17169774</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Noma</surname><given-names>K</given-names></name><name><surname>Yoshizumi</surname><given-names>M</given-names></name><name><surname>Kihara</surname><given-names>Y</given-names></name></person-group><article-title>Endothelial function and oxidative stress in
cardiovascular diseases</article-title><source>Circ J</source><year>2009</year><volume>73</volume><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1253/circj.CJ-08-1102</pub-id><pub-id pub-id-type="pmid">19194043</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aellig</surname><given-names>WH</given-names></name></person-group><article-title>A new technique for recording compliance of human hand
veins</article-title><source>Br J Clin Pharmacol</source><year>1981</year><volume>11</volume><fpage>237</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.1981.tb00527.x</pub-id><pub-id pub-id-type="pmid">7213525</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signori</surname><given-names>LU</given-names></name><name><surname>da Silva</surname><given-names>AM</given-names></name><name><surname>Plentz</surname><given-names>RD</given-names></name><name><surname>Moreno</surname><given-names>H</given-names><suffix>Jr</suffix></name><name><surname>Irigoyen</surname><given-names>MC</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name></person-group><article-title>Reversal of postprandial endothelial dysfunction by
cyclooxygenase inhibition in healthy volunteers</article-title><source>J Cardiovasc Pharmacol</source><year>2009</year><volume>54</volume><fpage>90</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e3181abc26f</pub-id><pub-id pub-id-type="pmid">19546816</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signori</surname><given-names>LU</given-names></name><name><surname>Vargas da Silva</surname><given-names>AM</given-names></name><name><surname>Della Mea Plentz</surname><given-names>R</given-names></name><name><surname>Geloneze</surname><given-names>B</given-names></name><name><surname>Moreno</surname><given-names>H</given-names><suffix>Jr</suffix></name><name><surname>Bello-Klein</surname><given-names>A</given-names></name><etal/></person-group><article-title>Reduced venous endothelial responsiveness after oral
lipid overload in healthy volunteers</article-title><source>Metabolism</source><year>2008</year><volume>57</volume><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2007.08.012</pub-id><pub-id pub-id-type="pmid">18078866</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>AM</given-names></name><name><surname>Signori</surname><given-names>LU</given-names></name><name><surname>Plentz</surname><given-names>RD</given-names></name><name><surname>Moreno</surname><given-names>H</given-names><suffix>Jr</suffix></name><name><surname>Barros</surname><given-names>E</given-names></name><name><surname>Bello-Klein</surname><given-names>A</given-names></name><etal/></person-group><article-title>Hemodialysis improves endothelial venous function in
end-stage renal disease</article-title><source>Braz J Med Biol Res</source><year>2008</year><volume>41</volume><fpage>482</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2008000600008</pub-id><pub-id pub-id-type="pmid">18622493</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Signori</surname><given-names>LU</given-names></name><name><surname>Quadros</surname><given-names>AS</given-names></name><name><surname>Sbruzzi</surname><given-names>G</given-names></name><name><surname>Dipp</surname><given-names>T</given-names></name><name><surname>Lopes</surname><given-names>RD</given-names></name><name><surname>Schaan</surname><given-names>BD</given-names></name></person-group><article-title>Endothelial function in patients with slow coronary flow
and normal coronary angiography</article-title><source>Clinics</source><year>2012</year><volume>67</volume><fpage>677</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.6061/clinics/2012(06)22</pub-id><pub-id pub-id-type="pmid">22760911</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffolo</surname><given-names>RR</given-names><suffix>Jr</suffix></name></person-group><article-title>Distribution and function of peripheral
alpha-adrenoceptors in the cardiovascular system</article-title><source>Pharmacol Biochem Behav</source><year>1985</year><volume>22</volume><fpage>827</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/0091-3057(85)90535-0</pub-id><pub-id pub-id-type="pmid">2989947</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piascik</surname><given-names>MT</given-names></name><name><surname>Perez</surname><given-names>DM</given-names></name></person-group><article-title>Alpha1-adrenergic receptors: new insights and
directions</article-title><source>J Pharmacol Exp Ther</source><year>2001</year><volume>298</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">11454900</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertovaara</surname><given-names>A</given-names></name></person-group><article-title>Noradrenergic pain modulation</article-title><source>Prog Neurobiol</source><year>2006</year><volume>80</volume><fpage>53</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2006.08.001</pub-id><pub-id pub-id-type="pmid">17030082</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grisanti</surname><given-names>LA</given-names></name><name><surname>Woster</surname><given-names>AP</given-names></name><name><surname>Dahlman</surname><given-names>J</given-names></name><name><surname>Sauter</surname><given-names>ER</given-names></name><name><surname>Combs</surname><given-names>CK</given-names></name><name><surname>Porter</surname><given-names>JE</given-names></name></person-group><article-title>Alpha1-adrenergic receptors positively regulate
Toll-like receptor cytokine production from human monocytes and
macrophages</article-title><source>J Pharmacol Exp Ther</source><year>2011</year><volume>338</volume><fpage>648</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1124/jpet.110.178012</pub-id><pub-id pub-id-type="pmid">21571945</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>EW</given-names></name><name><surname>Audette</surname><given-names>K</given-names></name><name><surname>Athman</surname><given-names>GA</given-names></name><name><surname>Nguyen</surname><given-names>HO</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name><name><surname>Fairbanks</surname><given-names>CA</given-names></name></person-group><article-title>Transcutaneous electrical nerve stimulation activates
peripherally located alpha-2A adrenergic receptors</article-title><source>Pain</source><year>2005</year><volume>115</volume><fpage>364</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2005.03.027</pub-id><pub-id pub-id-type="pmid">15911163</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CC</given-names></name><name><surname>Johnson</surname><given-names>MI</given-names></name><name><surname>McDonough</surname><given-names>S</given-names></name><name><surname>Cramp</surname><given-names>F</given-names></name></person-group><article-title>The effect of transcutaneous electrical nerve
stimulation on local and distal cutaneous blood flow following a prolonged heat
stimulus in healthy subjects</article-title><source>Clin Physiol Funct Imaging</source><year>2007</year><volume>27</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1111/j.1475-097X.2007.00731.x</pub-id><pub-id pub-id-type="pmid">17445066</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lazarou</surname><given-names>L</given-names></name><name><surname>Kitsios</surname><given-names>A</given-names></name><name><surname>Lazarou</surname><given-names>I</given-names></name><name><surname>Sikaras</surname><given-names>E</given-names></name><name><surname>Trampas</surname><given-names>A</given-names></name></person-group><article-title>Effects of intensity of Transcutaneous Electrical Nerve
Stimulation (TENS) on pressure pain threshold and blood pressure in healthy
humans: A randomized, double-blind, placebo-controlled trial</article-title><source>Clin J Pain</source><year>2009</year><volume>25</volume><fpage>773</fpage><lpage>780</lpage><pub-id pub-id-type="doi">10.1097/AJP.0b013e3181a7ece3</pub-id><pub-id pub-id-type="pmid">19851157</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichler</surname><given-names>HG</given-names></name><name><surname>Ford</surname><given-names>GA</given-names></name><name><surname>Blaschke</surname><given-names>TF</given-names></name><name><surname>Swislocki</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>BB</given-names></name></person-group><article-title>Responsiveness of superficial hand veins to
phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin
therapy</article-title><source>J Clin Invest</source><year>1989</year><volume>83</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1172/JCI113845</pub-id><pub-id pub-id-type="pmid">2562959</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>DM</given-names></name><name><surname>Papay</surname><given-names>RS</given-names></name><name><surname>Shi</surname><given-names>T</given-names></name></person-group><article-title>Alpha1-adrenergic receptor stimulates interleukin-6
expression and secretion through both mRNA stability and transcriptional
regulation: involvement of p38 mitogen-activated protein kinase and nuclear
factor-kappaB</article-title><source>Mol Pharmacol</source><year>2009</year><volume>76</volume><fpage>144</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1124/mol.108.054320</pub-id><pub-id pub-id-type="pmid">19363165</pub-id></element-citation></ref></ref-list></back></article>